Augmedix, Inc. (AUGX) Stock

About Augmedix, Inc.

Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.

Augmedix, Inc. is headquartered in US.

Augmedix, Inc. (AUGX) stock trades at $2.35 with a market capitalization of $115.91M. The stock is valued at a price-to-earnings (P/E) ratio of -5.33, price-to-book of 4.42, price-to-sales of 2.58. Over the past 52 weeks the stock has ranged between $0.73 and $6.25, and currently trades 62.4% below its 52-week high.

On profitability, Augmedix, Inc. generates a return on equity (ROE) of -154.69%, return on capital employed of -43.58%, an operating margin of -41.87%, a net profit margin of -42.74%.

Official website: www.augmedix.com